These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 28103626)
1. Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic. Doycheva I; Watt KD; Alkhouri N Hepatology; 2017 Jun; 65(6):2100-2109. PubMed ID: 28103626 [TBL] [Abstract][Full Text] [Related]
2. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Estes C; Razavi H; Loomba R; Younossi Z; Sanyal AJ Hepatology; 2018 Jan; 67(1):123-133. PubMed ID: 28802062 [TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments. Roeb E; Geier A Z Gastroenterol; 2019 Apr; 57(4):508-517. PubMed ID: 30965381 [TBL] [Abstract][Full Text] [Related]
4. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience. Perumpail RB; Wong RJ; Ahmed A; Harrison SA Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831 [TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. Streba LA; Vere CC; Rogoveanu I; Streba CT World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859 [TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030. Alswat K; Aljumah AA; Sanai FM; Abaalkhail F; Alghamdi M; Al Hamoudi WK; Al Khathlan A; Al Quraishi H; Al Rifai A; Al Zaabi M; Babatin MA; Estes C; Hashim A; Razavi H Saudi J Gastroenterol; 2018; 24(4):211-219. PubMed ID: 29956688 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease. Satapathy SK; Sanyal AJ Semin Liver Dis; 2015 Aug; 35(3):221-35. PubMed ID: 26378640 [TBL] [Abstract][Full Text] [Related]
8. Early life programming and the risk of non-alcoholic fatty liver disease. Lynch C; Chan CS; Drake AJ J Dev Orig Health Dis; 2017 Jun; 8(3):263-272. PubMed ID: 28112071 [TBL] [Abstract][Full Text] [Related]
9. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Takahashi Y; Fukusato T World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones. García-Monzón C; Vargas-Castrillón J; Porrero JL; Alonso MT; Bonachía O; Castillo MJ; Marcos A; Quirós E; Ramos B; Sánchez-Cabezudo C; Villar S; Sáez A; Rodríguez de Cía J; del Pozo E; Vega-Piris L; Soto-Fernández S; Lo Iacono O; Miquilena-Colina ME Liver Int; 2015 Aug; 35(8):1983-91. PubMed ID: 25708133 [TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World. Sayiner M; Koenig A; Henry L; Younossi ZM Clin Liver Dis; 2016 May; 20(2):205-14. PubMed ID: 27063264 [TBL] [Abstract][Full Text] [Related]
13. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Younossi ZM; Blissett D; Blissett R; Henry L; Stepanova M; Younossi Y; Racila A; Hunt S; Beckerman R Hepatology; 2016 Nov; 64(5):1577-1586. PubMed ID: 27543837 [TBL] [Abstract][Full Text] [Related]
14. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Younossi ZM; Koenig AB; Abdelatif D; Fazel Y; Henry L; Wymer M Hepatology; 2016 Jul; 64(1):73-84. PubMed ID: 26707365 [TBL] [Abstract][Full Text] [Related]
15. [Mechanism Analysis and Prevention of Pathogenesis of Nonalcoholic Steatohepatitis]. Nakajima T; Naito H Nihon Eiseigaku Zasshi; 2015; 70(3):197-204. PubMed ID: 26411937 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update. Athyros VG; Tziomalos K; Katsiki N; Doumas M; Karagiannis A; Mikhailidis DP World J Gastroenterol; 2015 Jun; 21(22):6820-34. PubMed ID: 26078558 [TBL] [Abstract][Full Text] [Related]